Brad Walsh
CEO
Cancer
Minomic
Australia
Biography
Dr. Brad Walsh brings over 30 years of experience in biotechnology business and has enjoyed a successful career commercialising immunoassay kits, proteomics technologies and consumables, and bioinformatics software. His products are being sold and supplied by major US corporations, such as Bio-Rad Laboratories. He is the founder of Minomic and in the early 2000’s started the predecessor of Minomic International Ltd as a private company, raising over $5M in equity investment and non-dilutive funding. In the mid-90’s he was the inaugural General Manager of an Australian National Research Facility, which was the world leader in the groundbreaking new field of proteomics. Prior to this, he led research groups in public institutions such as CSIRO, universities, and hospitals. His expertise and opinion as a thought leader and technologist has been eagerly sought by industry and government. He currently holds the position of Adjunct Professor at Macquarie University, Sydney, Australia.
Research Interest
Cancer